Nature Publishing Group has launched a new web-based publication, Nature China. Nature China seeks to highlight the best scientific research published in Mainland China and Hong Kong in one convenient portal. AstraZeneca, as sponsor, will support the website for the next two years. In the past decade, the output of research papers from China in the Thompson ISI database has soared from 10,000 papers a year to more than 80,000, which is the same numerical level as the United Kingdom and Japan. The number of very high impact papers (citations in excess of 20) from China has increased ten-fold to several hundred. Nature China is dedicated to highlighting the best research from mainland China and Hong Kong, to provide scientists from around the world with a convenient portal into research drawn from across the scientific and medical literature in all disciplines.
The website is currently in beta form as an archive is built extending back over the past six years to provide short summaries of some of the best research articles published from China in Nature journals and other leading scientific publications since 2000. In the case of Nature journals, access to the original full text articles is also provided. Once the archive is complete in April, each week thereafter, Nature China editors will select the best recently published research and provide a summary of the results. Readers can also recommend papers to be included in Nature China and vote/comment on those suggestions. The best of these, chosen by the site’s users, will be included within the Nature China archive.
Futher explanation about Nature China can be found on the site’s “”http://www.nature.com/nchina/recommended/faq.html">frequently asked questions" page.
This month’s featured papers on Nature China.